Autophagy—A key pathway for cardiac health and longevity
Year: 2018
Type: review
Abstract: As average life expectancy continues to rise in the developed world, age-associated pathologies are increasing in prevalence. The hallmarks of cardiac ageing include cardiomyocyte loss, fibrosis and hypertrophy, all of which contribute to an increased incidence of cardiac disease. At the molecular level, cellular ageing is characterized by increased ROS production, mitochondrial dysfunction and the accumulation of damaged proteins and organelles. Cardiomyocytes and other senescent cell types rely upon autophagy, a lysosome-mediated degradation pathway, to remove potentially toxic protein aggregates and damaged organelles from the cellular milieu. However, increasing lines of evidence point to an age-associated decrease in cardiomyocyte autophagy, with predictably negative consequences for cardiac function and health. Conversely, stimulation of autophagy has been shown to improve cellular health and cardiac function and to increase lifespan in numerous model organisms. Clearly, autophagy represents a critical pathway for cellular vitality, as well as a promising therapeutic target for the treatment of age-related cardiac pathologies. In this review, we will discuss the mechanism of autophagy and its regulation in the cell, the role of autophagy in the ageing heart, and how the autophagy pathway might be targeted to improve cardiac health.
Source: Acta Physiologica
DOI: 10.1111/apha.13074
Authors: B. P. Woodall, Å. B. Gustafsson
Institution: University of California San Diego
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: green
Awards: Mitochondrial Quality Control in the Aging Myocardium, G2420302882, Regulation of Mitochondrial Autophagy by Parkin, MCL-1 is a critical regulator of mitochondrial dynamics and function in myocytes, Role of the Endosomal-Lysosomal Pathway in Mitochondrial Quality Control, Training in Cardiovascular Physiology and Pharmacology
OpenAlex ID: W2800119026
